CELEX ID: 32010R1238

--- ENGLISH ---

Document:
31.12.2010
EN
Official Journal of the European Union
L 348/36
REGULATION (EU) No 1238/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 15 December 2010
amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 207 thereof,
Having regard to the proposal from the European Commission,
After transmission of the draft legislative act to the national parliaments,
Acting in accordance with the ordinary legislative procedure 
(
1
)
,
Whereas:
(1)
In the course of the Uruguay Round negotiations, the Community and a number of countries agreed that duty-free treatment should be granted to pharmaceutical products falling within the Harmonised System (HS) Chapter 30 and HS headings 2936, 2937, 2939 and 2941 as well as to designated pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization, specified salts, esters and hydrates of such INNs, and designated pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals.
(2)
The results of the discussions, as set out in the Record of Discussions, were incorporated into the tariff schedules of the participants annexed to the Marrakesh Protocol to the General Agreement on Tariffs and Trade (GATT) 1994.
(3)
Participants concluded that representatives of World Trade Organization (WTO) members, party to the Record of Discussions, would meet under the auspices of the Council for Trade in Goods of the WTO, normally at least once every three years, to review the product coverage with a view to including, by consensus, additional pharmaceutical products for tariff elimination.
(4)
Three such reviews have taken place with the result that a certain number of additional INNs and pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals have been granted duty-free treatment, that some of those intermediates have been transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs has been expanded.
(5)
A fourth review was deemed appropriate and was launched in 2009. It concluded that a certain number of additional INNs and pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals should be granted duty-free treatment, that some of those intermediates already included in the pharmaceutical sectoral arrangement and its revisions should be transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs should be expanded.
(6)
Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff 
(
2
)
 established the Combined Nomenclature (CN) and set out the conventional duty rates of the Common Customs Tariff.
(7)
Regulation (EEC) No 2658/87 should therefore be amended accordingly.
(8)
In order to ensure that the measures provided for in this Regulation apply from 1 January 2011, it should enter into force on the day following that of its publication,
HAVE ADOPTED THIS REGULATION:
Article 1
Annexes 3, 4 and 6 of Section II of Part Three of Annex I to Regulation (EEC) No 2658/87 (Lists of pharmaceutical substances which qualify for duty-free treatment) are hereby amended as follows:
1.
As from 1 January 2011 the Union shall extend duty-free treatment to the INNs listed in Annex I.
2.
As from 1 January 2011 the list of prefixes and suffixes which, in combination with the INNs included in the pharmaceutical sectoral arrangement and its revisions, describe the salts, esters or hydrates of INNs which are also eligible for duty-free treatment, on condition that they are classifiable in the same six-digit HS subheading as the corresponding INN, shall be amended as set out in Annex II.
3.
As from 1 January 2011 the Union shall extend duty-free treatment to the pharmaceutical intermediates used in the production and manufacture of finished pharmaceuticals, listed in Annex III.
4.
As from 1 January 2011 the pharmaceutical intermediates listed in Annex IV shall be withdrawn from the list of such compounds receiving duty-free treatment.
Article 2
This Regulation shall enter into force on the day following that of its publication in the 
Official Journal of the European Union
.
It shall apply from 1 January 2011.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Strasbourg, 15 December 2010.
For the European Parliament
The President
J. BUZEK
For the Council
The President
O. CHASTEL
(
1
)
  Position of the European Parliament of 23 November 2010 (not yet published in the Official Journal) and decision of the Council of 10 December 2010.
(
2
)
  
            
OJ L 256, 7.9.1987, p. 1
.
ANNEX I
List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Annex I to Regulation (EEC) No 2658/87
CN code
CAS RN
Name
2842 90 80
119175-48-3
fermagate
2843 90 90
759457-82-4
padeliporfin
2844 40 30
123748-56-1
iodofiltic acid (
)
2904 10 00
21668-77-9
eprodisate
2906 19 00
199798-84-0
elocalcitol
2909 30 90
24150-24-1
terameprocol
2916 19 95
81485-25-8
peretinoin
2916 39 00
51543-40-9
tarenflurbil
2918 19 98
174022-42-5
bevirimat
2919 90 00
258516-89-1
fospropofol
2920 90 85
163133-43-5
naproxcinod
2921 19 99
3687-18-1
tramiprosate
2922 19 85
68392-35-8
afimoxifene
2922 19 85
753449-67-1
ronacaleret
2922 29 00
433265-65-7
faxeladol
2922 50 00
121524-08-1
amibegron
2922 50 00
329773-35-5
cinaciguat
2922 50 00
643094-49-9
fasobegron
2923 10 00
856676-23-8
choline fenofibrate
2924 29 98
847353-30-4
arbaclofen placarbil
2924 29 98
194785-19-8
bedoradrine
2924 29 98
194085-75-1
carisbamate
2924 29 98
254750-02-2
emricasan
2924 29 98
355129-15-6
eprotirome
2924 29 98
402567-16-2
firategrast
2924 29 98
478296-72-9
gabapentin enacarbil
2924 29 98
15866-90-7
incyclinide
2924 29 98
202844-10-8
indantadol
2924 29 98
96847-55-1
levomilnacipran
2924 29 98
608137-32-2
lisdexamfetamine
2924 29 98
652990-07-3
milveterol
2924 29 98
181816-48-8
ombrabulin
2924 29 98
289656-45-7
senicapoc
2925 19 95
19171-19-8
pomalidomide
2928 00 90
22033-87-0
olesoxime
2928 00 90
2675-35-6
sivifene
2928 00 90
816458-31-8
tecovirimat
2928 00 90
238750-77-1
tosedostat
2928 00 90
149647-78-9
vorinostat
2929 90 00
31645-39-3
palifosfamide
2930 90 99
608141-41-9
apremilast
2930 90 99
216167-92-9
camobucol
2930 90 99
211513-37-0
dalcetrapib
2930 90 99
69819-86-9
darinaparsin
2930 90 99
488832-69-5
elesclomol
2930 90 99
216167-95-2
elsibucol
2930 90 99
168682-53-9
ezatiostat
2930 90 99
58569-55-4
metenkefalin
2930 90 99
887148-69-8
monepantel
2930 90 99
603139-19-1
odanacatib
2930 90 99
162520-00-5
salirasib
2930 90 99
216167-82-7
succinobucol
2930 90 99
125961-82-2
tipelukast
2931 00 99
125973-56-0
amsilarotene
2932 19 00
253128-41-5
eribulin
2932 19 00
186953-56-0
pafuramidine
2932 29 85
195883-06-8
omtriptolide
2932 99 00
664338-39-0
arterolane
2932 99 00
183133-96-2
cabazitaxel
2932 99 00
401925-43-7
celivarone
2932 99 00
461432-26-8
dapagliflozin
2932 99 00
118457-15-1
dexnebivolol
2932 99 00
156294-36-9
larotaxel
2932 99 00
118457-16-2
levonebivolol
2932 99 00
83461-56-7
mifamurtide
2932 99 00
117570-53-3
vadimezan
2933 19 90
496775-61-2
eltrombopag
2933 19 90
206884-98-2
niraxostat
2933 19 90
410528-02-8
palovarotene
2933 19 90
376592-42-6
totrombopag
2933 29 90
183659-72-5
catramilast
2933 29 90
944263-65-4
demiditraz
2933 29 90
867153-61-5
dulanermin
2933 29 90
320367-13-3
lixisenatide
2933 29 90
698389-00-3
rolipoltide
2933 29 90
697766-75-9
velafermin
2933 39 99
147084-10-4
alcaftadine
2933 39 99
54-96-6
amifampridine
2933 39 99
249921-19-5
anamorelin
2933 39 99
319460-85-0
axitinib
2933 39 99
208110-64-9
befiradol
2933 39 99
330942-05-7
betrixaban
2933 39 99
201034-75-5
daporinad
2933 39 99
209783-80-2
entinostat
2933 39 99
412950-27-7
goxalapladib
2933 39 99
218791-21-0
imisopasem manganese
2933 39 99
103129-82-4
levamlodipine
2933 39 99
154357-42-3
levonadifloxacin
2933 39 99
108147-54-2
migalastat
2933 39 99
453562-69-1
motesanib
2933 39 99
139145-27-0
parogrelil
2933 39 99
459856-18-9
pexacerfont
2933 39 99
706779-91-1
pimavanserin
2933 39 99
362665-56-3
pitolisant
2933 39 99
861151-12-4
rosonabant
2933 39 99
701977-09-5
taranabant
2933 39 99
189950-11-6
tropantiol
2933 39 99
793655-64-8
vapitadine
2933 39 99
139290-65-6
volinaserin
2933 49 90
141388-76-3
besifloxacin
2933 49 90
697761-98-1
elvitegravir
2933 49 90
185055-67-8
ferroquine
2933 49 90
445041-75-8
intiquinatine
2933 49 90
378746-64-6
nemonoxacin
2933 49 90
245765-41-7
ozenoxacin
2933 49 90
412950-08-4
rilapladib
2933 49 90
871224-64-5
almorexant
2933 49 90
863029-99-6
balamapimod
2933 49 90
698387-09-6
neratinib
2933 49 90
154652-83-2
tezampanel
2933 49 90
128253-31-6
veliflapon
2933 59 95
791828-58-5
aderbasib
2933 59 95
840486-93-3
adipiplon
2933 59 95
850649-61-5
alogliptin
2933 59 95
859212-16-1
bafetinib
2933 59 95
380843-75-4
bosutinib
2933 59 95
839712-12-8
cariprazine
2933 59 95
414910-27-3
casopitant
2933 59 95
288383-20-0
cediranib
2933 59 95
849550-05-6
cevipabulin
2933 59 95
827318-97-8
danusertib
2933 59 95
356057-34-6
darapladib
2933 59 95
501000-36-8
dutacatib
2933 59 95
247257-48-3
fimasartan
2933 59 95
3432-99-3
folitixorin
2933 59 95
668270-12-0
linagliptin
2933 59 95
441798-33-0
macitentan
2933 59 95
641571-10-0
nilotinib
2933 59 95
763113-22-0
olaparib
2933 59 95
686344-29-6
otenabant
2933 59 95
625115-55-1
riociguat
2933 59 95
486460-32-6
sitagliptin
2933 59 95
425637-18-9
sotrastaurin
2933 59 95
309913-83-5
talmapimod
2933 59 95
113857-87-7
talotrexin
2933 59 95
274693-27-5
ticagrelor
2933 59 95
306296-47-9
vicriviroc
2933 69 80
775351-65-0
imeglimin
2933 79 00
461443-59-4
aplaviroc
2933 79 00
189691-06-3
bremelanotide
2933 79 00
813452-18-5
carmegliptin
2933 79 00
405169-16-6
dovitinib
2933 79 00
536748-46-6
eribaxaban
2933 79 00
473289-62-2
ilepatril
2933 79 00
180694-97-7
mimopezil
2933 79 00
579475-18-6
orvepitant
2933 79 00
449811-01-2
pamapimod
2933 79 00
248282-01-1
paquinimod
2933 79 00
380917-97-5
perampanel
2933 79 00
552292-08-7
rolapitant
2933 79 00
425386-60-3
semagacestat
2933 79 00
515814-01-4
voclosporin
2933 99 80
481629-87-2
aleplasinin
2933 99 80
394730-60-0
boceprevir
2933 99 80
649735-63-7
brivanib alaninate
2933 99 80
483369-58-0
denagliptin
2933 99 80
284019-34-7
denibulin
2933 99 80
481631-45-2
diaplasinin
2933 99 80
272105-42-7
disitertide
2933 99 80
227318-71-0
epetirimod
2933 99 80
259793-96-9
favipiravir
2933 99 80
871576-03-3
flovagatran
2933 99 80
229305-39-9
golotimod
2933 99 80
258818-34-7
larazotide
2933 99 80
571170-77-9
laropiprant
2933 99 80
616202-92-7
lorcaserin
2933 99 80
868771-57-7
melogliptin
2933 99 80
803712-67-6
obatoclax
2933 99 80
404950-80-7
panobinostat
2933 99 80
625114-41-2
piragliatin
2933 99 80
74847-35-1
pyronaridine
2933 99 80
872178-65-9
rabeximod
2933 99 80
355151-12-1
rotigaptide
2933 99 80
497221-38-2
rusalatide
2933 99 80
187602-11-5
sofigatran
2933 99 80
227318-75-4
sotirimod
2933 99 80
402957-28-2
telaprevir
2933 99 80
848084-83-3
tigapotide
2933 99 80
393105-53-8
tiplasinin
2933 99 80
620948-93-8
vabicaserin
2933 99 80
794466-70-9
vernakalant
2934 10 00
544417-40-5
capadenoson
2934 10 00
302962-49-8
dasatinib
2934 10 00
223132-37-4
inolitazone
2934 10 00
241479-67-4
isavuconazole
2934 10 00
338990-84-4
isavuconazonium chloride
2934 10 00
607723-33-1
lobeglitazone
2934 10 00
280782-97-0
managlinat dialanetil
2934 10 00
790299-79-5
masitinib
2934 10 00
223673-61-8
mirabegron
2934 10 00
501948-05-6
rosabulin
2934 10 00
447406-78-2
sodelglitazar
2934 10 00
760937-92-6
teneligliptin
2934 20 80
848344-36-5
bentamapimod
2934 20 80
870093-23-5
talarozole
2934 99 90
320345-99-1
aclidinium bromide
2934 99 90
222551-17-9
adoprazine
2934 99 90
207623-20-9
agatolimod
2934 99 90
475479-34-6
aleglitazar
2934 99 90
870524-46-2
amolimogene bepiplasmid
2934 99 90
875446-37-0
anacetrapib
2934 99 90
250386-15-3
apadenoson
2934 99 90
541550-19-0
apilimod
2934 99 90
160707-69-7
apricitabine
2934 99 90
147403-03-0
azilsartan
2934 99 90
863031-21-4
azilsartan medoxomil
2934 99 90
757942-43-1
bederocin
2934 99 90
627861-07-8
beperminogene perplasmid
2934 99 90
959961-96-7
bevasiranib
2934 99 90
769901-96-4
capeserod
2934 99 90
868540-17-4
carfilzomib
2934 99 90
872847-66-0
cenersen
2934 99 90
80295-38-1
conestat alfa
2934 99 90
903916-27-8
custirsen
2934 99 90
187865-22-1
derquantel
2934 99 90
134379-77-4
dexelvucitabine
2934 99 90
247046-52-2
dilopetine
2934 99 90
480449-70-5
edoxaban
2934 99 90
188181-42-2
elacytarabine
2934 99 90
98819-76-2
esreboxetine
2934 99 90
763903-67-9
fosalvudine tidoxil
2934 99 90
172673-20-0
fosaprepitant
2934 99 90
522664-63-7
ibodutant
2934 99 90
405159-59-3
idrabiotaparinux sodium
2934 99 90
188116-07-6
imepitoin
2934 99 90
335619-18-6
inakalant
2934 99 90
1391-36-2
lancovutide
2934 99 90
189059-71-0
lapaquistat
2934 99 90
327026-93-7
lensiprazine
2934 99 90
170632-47-0
lificiguat
2934 99 90
852313-25-8
litenimod
2934 99 90
1000120-98-8
mipomersen
2934 99 90
62253-63-8
nepidermin
2934 99 90
26833-87-4
omacetaxine mepesuccinate
2934 99 90
269718-84-5
pardoprunox
2934 99 90
219923-85-0
pramiconazole
2934 99 90
377727-87-2
preladenant
2934 99 90
524684-52-4
prinaberel
2934 99 90
865311-47-3
quarfloxin
2934 99 90
869884-78-6
radezolid
2934 99 90
496054-87-6
radiprodil
2934 99 90
518048-05-0
raltegravir
2934 99 90
787548-03-2
regrelor
2934 99 90
820957-38-8
retosiban
2934 99 90
572924-54-0
ridaforolimus
2934 99 90
128517-07-7
romidepsin
2934 99 90
93265-81-7
ropidoxuridine
2934 99 90
151823-14-2
sapacitabine
2934 99 90
379231-04-6
saracatinib
2934 99 90
791635-59-1
simotaxel
2934 99 90
119567-79-2
taribavirin
2934 99 90
332012-40-5
telatinib
2934 99 90
925681-61-4
trabedersen
2934 99 90
189003-92-7
trelanserin
2934 99 90
296251-72-4
velimogene aliplasmid
2934 99 90
904302-98-3
viquidacin
2934 99 90
872525-61-6
votucalis
2934 99 90
221877-54-9
zotarolimus
2935 00 90
197904-84-0
apricoxib
2935 00 90
769169-27-9
begacestat
2935 00 90
414864-00-9
belinostat
2935 00 90
313682-08-5
brecanavir
2935 00 90
839673-52-8
cevoglitazar
2935 00 90
358970-97-5
drinabant
2935 00 90
865200-20-0
giripladib
2935 00 90
464213-10-3
ibipinabant
2935 00 90
173424-77-6
laromustine
2935 00 90
398507-55-6
lodenafil carbonate
2935 00 90
136564-68-6
masilukast
2935 00 90
170569-88-7
mavacoxib
2935 00 90
862189-95-5
mirodenafil
2935 00 90
439687-69-1
nelivaptan
2935 00 90
691852-58-1
nesbuvir
2935 00 90
778576-62-8
oglemilast
2935 00 90
444731-52-6
pazopanib
2935 00 90
362505-84-8
relacatib
2935 00 90
243984-11-4
resatorvid
2935 00 90
519055-62-0
tasisulam
2935 00 90
186497-07-4
zibotentan
2936 29 00
104121-92-8
eldecalcitol
2936 29 00
31690-09-2
levomefolic acid
2937 19 00
782500-75-8
albiglutide
2937 19 00
348119-84-6
obinepitide
2937 19 00
295350-45-7
ozarelix
2937 19 00
275371-94-3
taspoglutide
2937 19 00
218949-48-5
tesamorelin
2937 19 00
22006-64-0
tridecactide
2937 22 00
132245-57-9
dexamethasone cipecilate
2937 22 00
397864-44-7
fluticasone furoate
2937 29 00
211254-73-8
lonaprisan
2937 50 00
333963-42-1
cobiprostone
2937 50 00
172740-14-6
posaraprost
2937 90 00
834153-87-6
elagolix
2937 90 00
609799-22-6
tasimelteon
2937 90 00
342577-38-2
velneperit
2939 19 00
73232-52-7
methylnaltrexone bromide
2939 59 00
136199-02-5
rolofylline
2939 99 00
850607-58-8
darotropium bromide
2939 99 00
187852-63-7
delimotecan
2940 00 00
9007-72-1
ferric carboxymaltose
2940 00 00
442201-24-3
remogliflozin etabonate
2940 00 00
408504-26-7
sergliflozin etabonate
2941 90 00
467214-20-6
alvespimycin
2941 90 00
677017-23-1
berubicin
2941 90 00
229016-73-3
ceftaroline fosamil
2941 90 00
318498-76-9
flopristin
2941 90 00
145435-72-9
gamithromycin
2941 90 00
325965-23-9
linopristin
2941 90 00
857402-23-4
retaspimycin
2941 90 00
305841-29-6
sagopilone
2941 90 00
75747-14-7
tanespimycin
2941 90 00
328898-40-4
tildipirosin
2941 90 00
222400-20-6
tomopenem
2941 90 00
63409-12-1
tylvalosin
3001 90 91
9041-08-1
semuloparin sodium
3002 10 91
792921-10-9
abagovomab
3002 10 91
910649-32-0
anrukinzumab
3002 10 91
648904-28-3
bavituximab
3002 10 91
402710-27-4
(light chain)
402710-25-2
(heavy chain)
canakinumab
3002 10 99
945228-49-9
citatuzumab bogatox
3002 10 91
880486-59-9
dacetuzumab
3002 10 91
615258-40-7
denosumab
3002 10 91
762260-74-2
efungumab
3002 10 91
89957-37-9
gantenerumab
3002 10 91
680188-33-4
ibalizumab
3002 10 91
477202-00-9
ipilimumab
3002 10 91
640735-09-7
iratumumab
3002 10 91
845816-02-6
lexatumumab
3002 10 91
903512-50-5
lucatumumab
3002 10 91
899796-83-9
milatuzumab
3002 10 91
677010-34-3
motavizumab
3002 10 91
676258-98-3
naptumomab estafenatox
3002 10 91
828933-51-3
nimotuzumab
3002 10 91
949142-50-1
obinutuzumab
3002 10 91
637334-45-3
ocrelizumab
3002 10 91
881191-44-2
otelixizumab
3002 10 91
372075-37-1
sontuzumab
3002 10 91
705287-60-1
stamulumab
3002 10 91
339086-80-5
tadocizumab
3002 10 91
592557-43-2
(light chain)
592557-41-0
(heavy chain)
tenatumomab
3002 10 91
876387-05-2
teplizumab
3002 10 91
918127-53-4
tigatuzumab
3002 10 91
745013-59-6
tremelimumab
3002 10 91
339986-90-2
tucotuzumab celmoleukin
3002 10 91
728917-18-8
veltuzumab
3002 10 91
896731-82-1
conatumumab
3002 10 91
892553-42-3
etaracizumab
3002 10 91
944548-38-3
foravirumab
3002 10 91
944548-37-2
rafivirumab
3002 10 91
880266-57-9
tanezumab
3002 10 91
815610-63-0
ustekinumab
3002 10 95
862111-32-8
aflibercept
3002 10 95
845264-92-8
atacicept
3002 10 95
909110-25-4
baminercept
3002 10 95
9001-27-8
beroctocog alfa
3002 10 95
879555-13-2
epoetin kappa
3002 10 95
762263-14-9
epoetin theta
3002 10 95
501081-76-1
rilonacept
3002 10 95
267639-76-9
romiplostim
3002 10 95
869858-13-9
thrombin alfa
3002 10 95
897936-89-9
vatreptacog alfa (activated)
3002 10 95
472960-22-8
albinterferon alfa-2b
3002 10 95
869881-54-9
briobacept
3002 10 95
606138-08-3
catridecacog
3002 10 95
716840-32-3
denenicokin
3002 10 95
931101-84-7
troplasminogen alfa
3002 10 99
934216-54-3
alacizumab pegol
3002 20 00
181477-43-0
disomotide
3002 20 00
181477-91-8
ovemotide
3002 20 00
915019-08-8
tertomotide
3002 20 00
295371-00-5
verpasep caltespen
3002 90 90
473553-86-5
alferminogene tadenovec
3002 90 90
929881-05-0
alipogene tiparvovec
3002 90 90
600735-73-7
contusugene ladenovec
3002 90 90
851199-59-2
linaclotide
3002 90 90
898830-54-1
sitimagene ceradenovec
3002 90 90
721946-42-5
transferrin aldifitox
3507 90 90
9026-00-0
bucelipase alfa
3507 90 90
885051-90-1
pegloticase
3507 90 90
884604-91-5
velaglucerase alfa
3911 90 99
892497-01-7
azoximer bromide
ANNEX II
List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Annex I to Regulation (EEC) No 2658/87, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition that they are classifiable in the same six-digit HS subheading as the corresponding INN
The references to ‘International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals and groups, comprehensive list 2004’ are replaced by ‘International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals, groups and others, comprehensive list 2007’.
The following prefixes or suffixes are added to the list included in Annex 4 to Annex I to Regulation (EEC) No 2658/87:
Preferred prefix or suffix
Synonym
Systematic name when different
alanetil (INNRG)
[(S)-1-ethoxy-1-oxo-propan-2-yl]amino (INNCN)
alaninate (INNRG)
L-alaninate (INNCN)
alapivoxil (INNRG)
L-alanyl, [(2,2-dimethylpropanoyl)oxy]metyl (INNCN)
aldifitox (INNRG)
(4-iminobutane-1,4-diyl)sulfanediyl[(3RS)-2,5-dioxopyrrolidine-1,3-diyl]-1,3-phenylenecarbonyl and forming an N-benzoyl derivative of a primary amine group of diphtheria [550-L-phenylalanine]toxin from 
Corynebacterium diphtheriae
-(26-560)-peptide (INNCN)
besudotox (INNRG)
L-lysyl-L-alanyl-L-serylglycylglycine (linker) fusion protein with des-(365-380)-[Asn
364
,Val
407
,Ser
515
,Gln
590
,Gln
606
,Arg
613
]exotoxin A (
Pseudomonas aeruginosa
)-(251-613)-peptide (toxin with region IA and first 16 residues of region IB deleted) (INNCN)
ceribate (INNRG)
rac-2,3-dihydroxypropyl carbonate (ester) (INNCN)
cipecilate (INNRG)
cyclohexanecarboxylate (ester), cyclopropanecarboxylate (ester) (INNCN)
dalanated (INNRG)
des-B30-alanine (INNCN)
enacarbil (INNRG)
{rac-1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl (INNCN)
estafenatox (INNRG)
glycylglycyl-L-proline (linker) fusion protein with enterotoxin type A (
Staphylococcus aureus
)-(1-33)-peptidyl-L-seryl[Ser
36
,Ser
37
,Glu
38
,Lys
39
,Ala
41
,Thr
46
,Thr
71
,Ala
72
,Ser
75
,Glu
76
,Glu
78
,Ser
80
,Ser
81
,Thr
214
,Ser
217
,Thr
219
,Ser
220
,Ser
222
,Ser
224
]enterotoxin type E (
Staphylococcus aureus
)-(32-230)-peptide (synthetic superantigen SEA/E-120) (INNCN)
etexilate (INNRG)
ethyl, (hexyloxy)carbonyl
fosamil (INNRG)
phosphono (INNCN)
glucuronide (INNRG)
β-D-glucopyranosiduronic acid [oside] (INNCN)
medocaril (INNRG)
[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl (INNCN)
paptox (INNRG)
protein PAP (
Phytolacca americana
 antiviral) (INNCN)
placarbil (INNRG)
(R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy}carbonyl) (INNCN)
The systematic name of the following prefix or suffix is amended as follows:
Preferred prefix or suffix
Synonym
Systematic name when different
aritox (INNRG)
ricin A chain (INNCN)
ANNEX III
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be added to the list of products receiving duty-free treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87
CN code
CAS RN
Name
2843 29 00
22199-08-2
[4-amino-N-(pyrimidin-2(1H)-ylidene-κN1)benzenesulfonamidato-κO]silver
2905 39 95
281214-27-5
(2R,3R)-2,3-dimethylbutane-1,4-diyl bis(4-methylbenzenesulfonate)
2905 59 98
441002-17-1
4-chlorobutyl 2-nitrobenzenesulfonate
2909 30 90
92878-95-0
2-(3-chloropropoxy)-1-methoxy-4-nitrobenzene
2909 30
503070-57-3
2-({2-[(6-bromohexyl)oxy]ethoxy}methyl)-1,3-dichlorobenzene
2909 30
461432-23-5
4-(5-bromo-2-chlorobenzyl)phenyl ethyl ether
2909 49 80
185954-75-0
(3R)-3-methoxydecan-1-ol
2909 49 80
85309-91-7
2-[(2,6-dichlorobenzyl)oxy]ethanol
2909 49 80
160969-03-9
2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl methanesulfonate
2909 50 00
167145-13-3
2-[2-(3-methoxyphenyl)ethyl]phenol
2910 20 00
15448-47-2
(2R)-2-methyloxirane
2910 90 00
62600-71-9
(2R)-2-(3-chlorophenyl)oxirane
2910 90 00
702687-42-1
(2R)-2-[(5-bromo-2,3-difluorophenoxy)methyl]oxirane
2910 90 00
683276-64-4
[(2R)-2-methyloxiran-2-yl]methyl 4-nitrobenzenesulfonate
2913 00 00
90035-34-0
4′-(trifluoromethyl)biphenyl-4-carbaldehyde
2914 40 90
17752-16-8
(3β)-3-hydroxycholest-5-en-24-one
2914 50 00
974-23-2
(3β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-one
2914 70 00
13054-81-4
4-chloro-heptane-3,5-dione
2914 70 00
10226-30-9
6-chlorohexan-2-one
2915 60 90
53064-79-2
iodomethyl pivalate
2915 90 00
22328-90-1
(3R)-3-methylhexanoic acid
2915 90 00
1069-66-5
sodium 2-propylpentanoate
2916 20 00
211515-46-7
1-(2-ethylbutyl)cyclohexanecarbonyl chloride
2916 20 00
381209-09-2
1-(2-ethylbutyl)cyclohexanecarboxylic acid
2916 20 00
7077-05-6
trans-4-(propan-2-yl)cyclohexanecarboxylic acid
2916 39 00
21900-39-0
5-fluoro-2-methylbenzoyl chloride
2916 39 00
17625-03-5
sodium hydrogen 3-sulfonatobenzoate
2917 19 90
76-72-2
diethyl ethyl(pentan-2-yl)propanedioate
2918 29 00
376592-58-4
5′-chloro-2′-hydroxy-3′-nitrobiphenyl-3-carboxylic acid
2918 99 90
709031-28-7
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic acid
2918 99 90
35480-52-5
2,5-bis(2,2,2-trifluoroethoxy)benzoic acid
2918 99 90
4651-67-6
(3α,5β)-3-hydroxy-7-oxocholan-24-oic acid
2918 99 90
52179-28-9
ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoate
2918 99 90
530141-60-7
methyl 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-hydroxyphenyl)propanoate
2920 90 10
91526-18-0
4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one
2921 49 00
334477-60-0
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]-N-methylethanamine
2921 49 00
376608-71-8
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate
2921 49 00
1034457-07-2
2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine hydrochloride
2921 49 00
945717-05-5
2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride
2921 49 00
89-97-4
2-chlorobenzylamine
2921 49 00
945717-43-1
N-(4-tert-butylbenzyl)-2-(4-chloro-3-ethylphenyl)ethanamine
2921 51 90
150812-21-8
N4-[(4-fluorophenyl)methyl]-2-nitro-1,4-benzenediamine
2922 19 85
1035455-90-3
(2R)-1-(5-bromo-2,3-difluorophenoxy)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}propan-2-ol hydrochloride
2922 19 85
0-00-0
[2-(chloromethyl)-4-(dibenzylamino)phenyl]methanol hydrochloride
2922 19 85
133-51-7
antimonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:1)
2922 19 85
1035455-87-8
ethyl (2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)prop-2-enoate hydrochloride
2922 19 85
702686-97-3
ethyl 3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)propanoate hydrochloride
2922 29 00
20059-73-8
2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamine
2922 49 85
848133-35-7
(2E)-4-(dimethylamino)but-2-enoic acid hydrochloride
2922 49 85
610300-07-7
(3S,5R)-3-amino-5-methyloctanoic acid
2922 49 85
610300-00-0
(3S,5R)-3-amino-5-methyloctanoic acid hydrochloride
2922 49 85
143785-86-8
4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid
2922 49 85
848949-85-9
4-fluoro-L-leucine – ethyl hydrogen sulfate (1:1)
2922 49 85
39068-93-4
methyl 2-(dimethylamino)-2-phenylbutanoate
2922 49 85
168619-25-8
methyl 3′-aminobiphenyl-3-carboxylate
2922 49 85
82834-12-6
N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanine
2922 49 85
94133-84-3
sodium 2-amino-2-phenylbutanoate
2922 50 00
503070-58-4
triphenylacetic acid – 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1)
2924 19 00
62009-47-6
2-aminomalonamide
2924 19 00
7355-58-0
N-(2-chloroethyl)acetamide
2924 29 98
361442-00-4
{2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}acetic acid
2924 29 98
266993-72-0
2,3-diaminobenzamide dihydrochloride
2924 29 98
168080-49-7
2-chloro-4-{[(5-fluoro-2-methylphenyl)carbonyl]amino}benzoic acid
2924 29 98
317374-08-6
2-methyl-4-{[(2-methylphenyl)carbonyl]amino}benzoic acid
2924 29 98
143785-84-6
4-(1-carbamoylcyclopropyl)-2,3,5-trifluorobenzoic acid
2924 29 98
143785-87-9
4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorobenzoic acid
2924 29 98
108166-22-9
4-{[(2-methylphenyl)carbonyl]amino}benzoic acid
2924 29 98
150812-23-0
ethyl {4-[(4-fluorobenzyl)amino]-2-nitrophenyl}carbamate
2924 29 98
22316-45-6
ethyl 3-[(5-chloro-2-nitrophenyl)(phenyl)amino]-3-oxopropanoate
2924 29 98
316173-29-2
methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentanecarboxylate
2924 29 98
1142-20-7
N-benzyloxycarbonyl-L-alanine
2924 29 98
84996-93-0
N-cyclohexyl-5-hydroxypentanamide
2924 29 98
579494-66-9
propyl {4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyphenyl}acetate
2925 19 95
265136-65-0
ethyl 3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]but-2-enoate
2926 90 95
855425-38-6
1-(2-ethylbutyl)cyclohexanecarbonitrile
2926 90 95
846023-24-3
2-cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide
2926 90 95
591769-05-0
3-cyclopentylprop-2-enenitrile
2926 90 95
20099-89-2
4-(bromoacetyl)benzonitrile
2926 90 95
474554-45-5
4,5-diethoxy-3-fluorobenzene-1,2-dicarbonitrile
2926 90 95
79370-78-8
5-hydroxybenzene-1,3-dicarbonitrile
2926 90 95
139481-28-0
methyl 2-{[(2′-cyanobiphenyl-4-yl)methyl]amino}-3-nitrobenzoate
2928 00 90
860035-10-5
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate
2928 00 90
910656-45-0
2-hydroxy-2-(trifluoromethyl)butanehydrazide
2928 00 90
95759-10-7
4-chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid
2928 00 90
473927-63-8
ethyl (2Z)-chloro[2-(4-methoxyphenyl)hydrazinylidene]ethanoate
2928 00 90
158671-29-5
N,2-dihydroxy-4-methylbenzamide
2928 00 90
84080-68-2
tert-butyl (2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate
2928 00 90
268544-50-9
tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate
2930 90 99
13459-62-6
{2-[(4-chlorophenyl)sulfanyl]phenyl}acetic acid
2930 90 99
211513-21-2
1-(2-ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide
2930 90 99
860035-07-0
1-{[(methylsulfanyl)carbonyl]oxy}ethyl 2-methylpropanoate
2930 90 99
893407-18-6
2,2,2-trifluoro-1-[4′-(methylsulfonyl)biphenyl-4-yl]ethanone
2930 90 99
60759-00-4
3,4-diethoxybenzenecarbothioamide
2930 90 99
21048-05-5
N-methylbenzenecarbothiohydrazide
2931 00 99
13682-94-5
(2-bromoethenyl)(trimethyl)silane
2931 00 99
914922-89-7
(2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamide
2931 00 99
914922-88-6
(2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-enamide
2931 00 99
871355-80-5
(4R)-2-bromo-7-{[tert-butyl(diphenyl)silyl]oxy}hept-1-en-4-yl 4-methylbenzenesulfonate
2931 00 99
89694-48-4
(5-chloro-2-methoxyphenyl)boronic acid
2931 00 99
701278-08-2
[(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-methoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1-yl]methanol
2931 00 99
701278-09-3
{(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]cyclopent-1-en-1-yl}methanol
2931 00 99
796967-18-5
1-(2-fluoro-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea
2931 00 99
172732-52-4
2-(1,3,2-dioxaborinan-2-yl)benzonitrile
2931 00 99
185411-12-5
methyl 3-(trimethylsilyl)pent-4-enoate
2932 19 00
253128-10-8
(1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylidene-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol
2932 19 00
441045-17-6
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one methanesulfonate
2932 29 85
916069-80-2
(4S)-4-(fluoromethyl)dihydrofuran-2(3H)-one
2932 29 85
63106-93-4
1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one
2932 29 85
7734-80-7
2-oxo-2H-chromene-6-carboxylic acid
2932 29 85
0-00-0
4-(4-fluorophenyl)-7-(isothiocyanatomethyl)-2H-chromen-2-one
2932 29 85
947408-91-5
6-[(2,4-dihydroxyphenyl)carbonyl]-2H-chromen-2-one
2932 29 85
947408-90-4
6-[(2,4-dimethoxyphenyl)carbonyl]-2H-chromen-2-one
2932 99 00
452342-08-4
(1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol
2932 99 00
99541-23-8
(1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-bis(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetate
2932 99 00
461432-25-7
(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
2932 99 00
196597-79-2
(2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylideneethanenitrile
2932 99 00
3308-94-9
2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane
2932 99 00
274693-53-7
[(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]carbamate
2932 99 00
185954-98-7
[6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-metoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-D-glucopyranose 1-(dihydrogen phosphate) tetrasodium salt
2932 99 00
136172-58-2
1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose
2932 99 00
196597-80-5
2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethanamine hydrochloride
2932 99 00
666860-59-9
2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propyl}carbamate
2932 99 00
117661-72-0
5-(chloromethyl)-6-methyl-1,3-benzodioxole
2932 99 00
959624-24-9
6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol
2932 99 00
960404-59-5
but-2-yne-1,4-diol – methyl 1-C-[4-chloro-3-(4-ethoxybenzyl)phenyl]-α-D-glucopyranoside (1:1)
2932 99 00
15826-37-6
disodium 5,5′-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate)
2932 99 00
204254-84-2
ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate
2932 99 00
99541-26-1
methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate
2932 99 00
114869-97-5
methyl 6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-glucopyranoside
2933 19 90
1035677-60-1
(4S)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide 2,3-dihydroxybutanedioate
2933 19 90
18048-64-1
2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one
2933 19 90
1035675-24-1
3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
2933 19 90
1028026-83-6
5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-one
2933 19 90
473921-12-9
5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile
2933 29 90
65902-59-2
2-bromo-4-nitro-1H-imidazole
2933 29 90
57531-37-0
2-chloro-4-nitro-1H-imidazole
2933 29 90
1000164-35-1
3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidyl-2-methylalanyl-L-α-glutamylglycine
2933 29 90
152074-97-0
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine
2933 29 90
781666-30-6
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine tetraacetate
2933 29 90
451470-33-0
methyl 3′-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)biphenyl-3-carboxylate
2933 39 99
925978-49-0
(+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-azabicyclo[3.2.1]octane
2933 39 99
876170-44-4
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
2933 39 99
741705-70-4
(2R)-phenyl[(2R)-piperidin-2-yl]ethanoic acid hydrochloride
2933 39 99
414910-13-7
(2S)-hydroxy(phenyl)ethanoic acid – (2R)-2-(4-fluoro-2-methylphenyl)piperidin-4-one (1:1)
2933 39 99
0-00-0
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole 4-methylbenzenesulfonate
2933 39 99
370882-57-8
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole dihydrochloride
2933 39 99
334618-23-4
(3R)-piperidin-3-amine dihydrochloride
2933 39 99
1062580-52-2
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
2933 39 99
27262-47-1
(S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
2933 39 99
105812-81-5
[(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methanol
2933 39 99
876068-51-8
[(3S,4S)-4-amino-1-(5,6-dichloropyridin-3-yl)pyrrolidin-3-yl]methanol
2933 39 99
871022-14-9
1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-benzimidazol-1-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)cyclobutanecarboxylic acid
2933 39 99
5421-92-1
1-(pyridin-4-yl)pyridinium chloride hydrochloride
2933 39 99
272776-12-2
1,1′-binaphthalene-2,2′-diol –5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole (1:1)
2933 39 99
871022-19-4
1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutanecarboxylic acid
2933 39 99
3613-73-8
2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
2933 39 99
179687-79-7
2-[(2-chloro-4-nitrophenoxy)methyl]pyridine
2933 39 99
122321-04-4
2-[methyl(pyridin-2-yl)amino]ethanol
2933 39 99
945405-37-8
2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridine 2,3-dihydroxybutanedioate
2933 39 99
936637-40-0
3,3′-piperidine-1,4-diyldipropan-1-ol 4-methylbenzenesulfonate
2933 39 99
88150-62-3
3-ethyl-5-methyl-4-(2-chlorophenyl)-2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
2933 39 99
84100-54-9
4-(ethylamino)piperidine-4-carboxamide
2933 39 99
873546-30-6
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis(N′-hydroxybenzenecarboximidamide)
2933 39 99
873546-74-8
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis[N′-(acetyloxy)benzenecarboximidamide]
2933 39 99
873546-38-4
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzenecarboximidamide trihydrochloride pentahydrate
2933 39 99
873546-80-6
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzonitrile
2933 39 99
78750-61-5
4-[(3-nitropyridin-2-yl)amino]phenol
2933 39 99
866109-93-5
4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenol 4-methylbenzenesulfonate
2933 39 99
927889-51-8
4-bromo-2,6-diethylpyridine 4-methylbenzenesulfonate
2933 39 99
691882-47-0
4-hydroxybenzoic acid – (2S,4E)-N-methyl-5-[5-(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-amine (1:1)
2933 39 99
876068-46-1
5,6-dichloro-N-(2,2-dimethoxyethyl)pyridin-3-amine
2933 39 99
1072-98-6
5-chloropyridin-2-amine
2933 39 99
298692-34-9
6-(chloroacetyl)pyridine-2-carboxylic acid
2933 39 99
550349-58-1
7-chloro-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indole-1-carboxamide
2933 39 99
414909-98-1
benzyl 2-(4-fluoro-2-methylphenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate
2933 39 99
56880-11-6
ethyl [(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetate
2933 39 99
548797-97-3
N-(2-{[(2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-hydroxyphenyl)acetamide
2933 39 99
0-00-0
N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-2,6-dichloro-3-(trifluoromethyl)benzamide hydrochloride
2933 39 99
329003-65-8
sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate hemipentahydrate
2933 49 10
417716-92-8
4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide methanesulfonate
2933 49 90
503291-53-0
2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chloro-2-(1H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylate 4-methylbenzenesulfonate
2933 49 90
103733-32-0
benzyl (3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride
2933 49 90
503293-98-9
(3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycarbonyl)decahydroisoquinoline-3-carboxylic acid
2933 49 90
503290-66-2
(3S,4aS,6S,8aR)-6-[3-chloro-2-(2H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylic acid hydrochloride
2933 49 90
134388-95-7
(3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoquinoline-3-carboxylic acid – (1R)-1-phenylethanamine (1:1)
2933 49 90
868210-14-4
4-(4-{[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-2-methyl-3,4-dihydroquinolin-1(2H)-yl]carbonyl}phenoxy)-2,2-dimethylbutanoic acid
2933 49 90
00-00-0
methyl 2-[(3R)-3-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl]benzoate hydrochloride
2933 49 90
848133-76-6
N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide
2933 59 95
869490-23-3
(3,3-difluoropyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanone
2933 59 95
941685-40-1
(3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
2933 59 95
941678-49-5
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
2933 59 95
941685-41-2
(3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
2933 59 95
957187-34-7
[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetic acid
2933 59 95
356058-42-9
{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}acetic acid
2933 59 95
0-00-0
2,3-dihydroxy-2,3-bis(phenylcarbonyl)butanedioic acid – ethyl [(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetate (1:1)
2933 59 95
90213-66-4
2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine
2933 59 95
3934-20-1
2,4-dichloropyrimidine
2933 59 95
451487-18-6
2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one
2933 59 95
865758-96-9
2-[(6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitrile
2933 59 95
934815-71-1
2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]amino}-2-methoxypyrimidin-4-yl)phenyl]-2-methylpropanoic acid phosphate
2933 59 95
722543-31-9
2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate
2933 59 95
1032066-96-8
2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl}-1,9-dihydro-6H-purin-6-one – methanesulfonate (2:1)
2933 59 95
540737-29-9
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
2933 59 95
1137917-12-4
3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-hydroxypropan-2-yl]oxy}benzoic acid – 1,4-diazabicyclo[2.2.2]octane (2:1)
2933 59 95
941685-39-8
3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
2933 59 95
941685-27-4
4-(1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine
2933 59 95
1780-26-3
4,6-dichloro-2-methylpyrimidine
2933 59 95
145783-14-8
4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine
2933 59 95
3680-69-1
4-chloro-7H-pyrrolo[2,3-d]pyrimidine
2933 59 95
61379-64-4
4-cyclopentylpiperazin-1-amine
2933 59 95
55112-42-0
4-methylpiperazine-1-carbonyl chloride hydrochloride
2933 59 95
0-00-0
5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methylpiperazin-1-yl)[1,2,4]triazolo[1,5-a]quinoline-4-carbonitrile – (2E)-but-2-enedioate (2:1) hydrate
2933 59 95
55293-96-4
5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde
2933 59 95
179688-01-8
7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one
2933 59 95
444731-74-2
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine
2933 59 95
0-00-0
N-(5-fluoro-3-methyl-1H-indol-1-yl)-4-methyl-2-(pyridin-2-yl)pyrimidine-5-carboxamide
2933 79 00
586414-48-4
(-)-3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide
2933 79 00
425663-71-4
(1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride
2933 79 00
813452-14-1
(4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one dihydrochloride
2933 79 00
5162-90-3
3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine
2933 79 00
536760-29-9
3-chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
2933 79 00
4876-10-2
4-(bromomethyl)quinolin-2(1H)-one
2933 79 00
5057-12-5
4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione
2933 79 00
54197-66-9
6-hydroxy-3,4-dihydroquinolin-2(1H)-one
2933 79 00
22246-18-0
7-hydroxy-3,4-dihydroquinolin-2(1H)-one
2933 79 00
536759-91-8
ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
2933 79 00
503614-91-3
ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
2933 79 00
586379-61-5
methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate
2933 99 80
709031-45-8
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate
2933 99 80
649735-46-6
(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol
2933 99 80
51077-14-6
(2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic acid
2933 99 80
631916-97-7
(2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl}azetidine-2-carboxamide – benzenesulphonic acid (1:1)
2933 99 80
80875-98-5
(2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid
2933 99 80
948846-40-0
(2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic acid – ethyl (3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate (1:1)
2933 99 80
1000164-36-2
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontan-42-oic acid
2933 99 80
22162-51-2
1-(2-nitrobenzyl)-1H-pyrrole-2-carbaldehyde
2933 99 80
35681-40-4
1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one
2933 99 80
166170-15-6
1-(tert-butoxycarbonyl)-2-methyl-D-proline
2933 99 80
796967-16-3
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea
2933 99 80
0-00-0
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea hydrochloride
2933 99 80
444731-72-0
2,3-dimethyl-2H-indazol-6-amine
2933 99 80
19686-05-6
2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
2933 99 80
912444-00-9
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
2933 99 80
912445-36-4
2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide dihydrochloride
2933 99 80
163457-23-6
3,3-difluoropyrrolidine hydrochloride
2933 99 80
239463-85-5
3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propyl benzoate (2R,3R)-2,3-dihydroxybutanedioate
2933 99 80
55321-99-8
3-oxo-3,4-dihydropyrazine-2-carboxamide
2933 99 80
952490-01-6
4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate
2933 99 80
942436-93-3
4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide
2933 99 80
942437-37-8
4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide
2933 99 80
288385-88-6
4-fluoro-2-methyl-1H-indol-5-ol
2933 99 80
503293-47-8
5-(2-chloro-6-fluorophenyl)-2H-tetrazole
2933 99 80
73963-42-5
5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole
2933 99 80
606143-52-6
5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide
2933 99 80
0-00-0
5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-indole-2-carboxamide
2933 99 80
872206-47-8
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate
2933 99 80
259793-88-9
6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide
2933 99 80
1137606-74-6
6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile – N-cyclohexylcyclohexanamine (1:1)
2933 99 80
261953-36-0
6-iodo-1H-indazole
2933 99 80
80076-47-7
8,9-difluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
2933 99 80
52602-39-8
9H-carbazol-4-ol
2933 99 80
145641-35-6
benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-carboxylate hydrochloride
2933 99 80
87269-87-2
benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylate hydrochloride
2933 99 80
1012065-72-3
ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline-3-carboxylate
2933 99 80
131707-24-9
ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate
2933 99 80
105152-95-2
ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
2933 99 80
139481-44-0
methyl 1-[(2′-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
2933 99 80
0-00-0
methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
2933 99 80
21688-11-9
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide
2933 99 80
361440-67-7
tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate
2933 99 80
709031-38-9
tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-1-carboxylate
2933 99 80
709031-43-6
tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate
2933 49 90
936359-25-0
methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoate
2934 10 00
110130-88-6
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethanoic acid
2934 10 00
68672-66-2
(2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethanoic acid
2934 10 00
291536-35-1
(5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-dione
2934 10 00
302964-24-5
2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide
2934 10 00
866920-24-3
3-[2-chloro-4-({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one
2934 10 00
752253-39-7
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine
2934 10 00
914361-45-8
L-lysine – {[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxy}methyl dihydrogen phosphate – ethanol (1:1:1)
2934 10 00
302964-08-5
N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide
2934 10 00
127660-04-2
sodium (2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoate
2934 99 90
17381-54-3
(1-benzothiophen-5-yl)acetic acid
2934 99 90
630100-90-2
(1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol
2934 99 90
220099-91-2
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine]
2934 99 90
220100-81-2
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] (S,S)-2,3-dihydroxybutanedioate
2934 99 90
161599-46-8
(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate
2934 99 90
690270-65-6
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) hydrochloride
2934 99 90
265121-04-8
(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:2)
2934 99 90
163680-80-6
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
2934 99 90
132335-46-7
(3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
2934 99 90
133413-70-4
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone
2934 99 90
503068-36-8
(5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
2934 99 90
452339-73-0
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
2934 99 90
877130-28-4
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one
2934 99 90
132335-44-5
(S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol
2934 99 90
812647-80-6
{(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl 3-chlorobenzoate
2934 99 90
00-00-0
1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one
2934 99 90
1029716-44-6
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
2934 99 90
165172-60-1
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione – 1-methylpyrrolidin-2-one (1:1)
2934 99 90
519187-97-4
1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol – (2Z)-2-butenedioate (1:1)
2934 99 90
127000-90-2
1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole
2934 99 90
710281-33-7
2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoic acid
2934 99 90
96803-30-4
2-(1-benzothiophen-5-yl)ethanol
2934 99 90
913695-00-8
2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1Hbenzimidazole, sodium salt (1:1)
2934 99 90
376608-74-1
2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2-(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol
2934 99 90
474554-48-8
2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanone
2934 99 90
530141-72-1
3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propanoic acid
2934 99 90
519188-55-7
3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazetidin-1-yl)propan-1-one
2934 99 90
519188-42-2
3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid
2934 99 90
753015-42-8
3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridine
2934 99 90
26638-53-9
3-chloro-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide
2934 99 90
499785-81-8
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide
2934 99 90
356782-84-8
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide
2934 99 90
6504-57-0
4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-ium methyl sulfate
2934 99 90
871484-32-1
4-[4-({3-[(4-deoxy-4-fluoro-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamide
2934 99 90
166964-09-6
4-chloro-3-methyl-1,2-oxazol-5-amine
2934 99 90
655233-39-3
4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride
2920 90 85
89729-09-9
5,7-dioxa-6-thiaspiro[2.5]octane-6-oxide
2934 99 90
388082-75-5
5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde – 4-methylbenzenesulfonate (1:1)
2934 99 90
4923-87-9
5-bromo-1-benzothiophene
2934 99 90
947408-95-9
6-(bromomethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-one
2934 99 90
947408-94-8
6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one
2934 99 90
67978-05-6
diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoate
2934 99 90
1001859-46-6
DNA (synthetic plasmid vector pCOR human interferon beta signal peptide fusion protein with 21-154-human acidic fibroblast growth factor-specifying)
2934 99 90
665058-78-6
DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp-T-sp-C-G-sp-T-sp-T)
2934 99 90
923591-06-4
methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxylate
2934 99 90
59337-92-7
methyl 3-(chlorosulfonyl)thiophene-2-carboxylate
2934 99 90
947409-01-0
methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on-6-yl)methoxy]phenyl]propionate
2934 99 90
85006-31-1
methyl 3-amino-4-methylthiophene-2-carboxylate
2934 99 90
893428-72-3
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine – (2E)-2-butenedioate (1:2)
2934 99 90
390800-88-1
N,N′,N′′-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutane-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropane-1,2-diyl]})tripyrazine-2-carboxamide
2934 99 90
112913-94-7
N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}acetamide
2934 99 90
120788-03-6
S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanethioate
2935 00 90
1198178-65-2
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium 4-methylbenzenesulfonate
2935 00 90
39570-96-2
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamide
2935 00 90
24310-36-9
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
2935 00 90
0-00-0
2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide di[(2E)-but-2-enedioate] hydrate
2935 00 90
941690-55-7
3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide
2935 00 90
6973-09-7
5-amino-2-methylbenzenesulfonamide
2935 00 90
193686-76-9
7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
2935 00 90
123664-84-6
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide
2935 00 90
149457-03-4
N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide
2935 00 90
149456-98-4
N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide
2935 00 90
141450-48-8
N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide hydrochloride
2935 00 90
289042-10-0
N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-methylmethanesulfonamide
2939 99 00
7689-03-4
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
2939 99 00
477-29-2
colchicoside
2940 00 00
604-69-3
1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose
2940 00 00
647834-15-9
2-(4-methoxybenzyl)thiophen-3-yl β-D-glucopyranoside
2941 90 00
76610-92-9
(6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3907 20 99
913976-27-9
poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester with 21N6, 21′N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6→15), (6′→15′) bis(disulfide)
ANNEX IV
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87 due to their transfer to the list of products receiving duty-free treatment included in Annex 3 to Annex I to Regulation (EEC) No 2658/87
CN code
CAS RN
Name
2915 39 00
2937 29 00
7753-60-8
17-alpha-hydroxy-3,20-dioxopregna-4,9(11)-diene-21-yl acetate
see anecortave (INN)
2920 90 85
163133-43-5
4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl) propanoate
see naproxcinod (INN)
2924 29 98
194085-75-1
2-(2-chlorophenyl)-2-hydroxyethyl carbamate
see carisbamate (INN)
2933 39 99
103129-82-4
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
see levamlodipine (INN)
2933 39 99
319460-85-0
N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamide
see axitinib (INN)
2934 10 00
302962-49-8
N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiazole-5-carboxamide
see dasatinib (INN)
2934 99 90
143491-57-0
(2R,5S)-4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
see emtricitabine(INN)
2934 99 90
98819-76-2
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine
see esreboxetine (INN)
2934 99 90
475479-34-6
(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid
see aleglitazar (INN)
2934 99 90
377727-87-2
2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl] piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amine
see preladenant (INN)
2934 99 90
189003-92-7
2-{7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-yl}acetamide
see trelanserin (INN)
2934 99 90
134379-77-4
4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one
see dexelvucitabine (INN)
2934 99 90
518048-05-0
potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidine-5-olate
see raltegravir (INN)
2935 00 90
170569-88-7
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide
see mavacoxib (INN)
2935 00 90
186497-07-4
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide
see zibotentan (INN)

Summary:
Duty-free treatment of specified pharmaceutical active ingredients
SUMMARY OF:
Regulation (EU) 
No 1238/2010
 – duty-free treatment of specified pharmaceutical active ingredients and products in finished pharmaceuticals
Regulation (EC) 
No 467/97
 – duty-free treatment of specified ingredients and products used in finished pharmaceuticals and withdrawing this treatment for others
WHAT IS THE AIM OF THE REGULATIONS?
The regulations incorporate into 
European Union
 (EU) law 
duty-free decisions for certain pharmaceuticals and active ingredients
. These were first taken in the 
Uruguay Round
 of international trade negotiations.
The items each have an 
international nonproprietary name
 (INN)
1
 and new ones have been added to the lists on several occasions.
Regulation (EU) 
No 1238/2010
 updates the lists after the fourth review launched in 2009.
Council Regulation (EC) 
No 467/97
 updates the lists after the first review.
KEY POINTS
Regulation (EU) 
No 1238/2010
It amends 
Annex I
 (lists of pharmaceutical substances qualifying for duty-free treatment) to Regulation (EEC) 
No 
2658/87
 setting out the EU’s 
combined nomenclature
.
It gives duty-free treatment from 
1 January 2011
 to: 
products with a 
World Health Organization
 international non-proprietary name (Annex I);
the 
list of prefixes and suffixes
 which, combined with INNs, describe their salts, esters or hydrates which are also eligible for duty-free treatment (Annex II);
pharmaceutical intermediates
 used to produce and manufacture finished pharmaceuticals (Annex III).
It removes certain pharmaceutical intermediates from the list of those receiving duty-free treatment (Annex IV).
Regulation (EC) 
No 467/97
It gives duty-free treatment from 
1 April 1997
 to: 
231 designated pharmaceutical active ingredients
 with an INN, along with their salts, esters and hydrates (
Annex I
);
234 designated products
 used to produce and manufacture finished pharmaceuticals (
Annex II
).
It expands the list of specified prefixes and suffixes of INNs eligible by adding 84 names to duty-free treatment (
Annex III
).
It removes 25 products – together with their salts, esters and hydrates – from duty-free treatment since their use was predominantly non-pharmaceutical (
Annex IV
).
FROM WHEN DO THE REGULATIONS APPLY?
Regulation (EU) 
No 1238/2010
 has applied since 
1 January 2011
.
Regulation (EC) 
No 467/97
 has applied since 
14 March 1997
.
BACKGROUND
During the Uruguay Round, the most important producers – the EU, the United States, Japan, Canada, Switzerland, Norway and China – agreed to reduce duties on pharmaceuticals to zero. The agreement covered over 6,000 products.
With the development of new drugs, reviews took place in 1995–1996, 1998 and 2006, adding almost 
2,400 products
. The fourth review added 718 new substances, bringing the total of duty-free pharmaceutical imports into the EU to 
8,619
.
For further information, see: 
International nonproprietary names programme and classification of medical products
 (World Health Organization).
KEY TERMS
International nonproprietary names (INN).
 Also known as generic names, they identify pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognised and that is classified as public property. The World Health Organization works closely with INN experts and national nomenclature committees to select a single name that is accepted worldwide for each active substance to be marketed as a pharmaceutical.
MAIN DOCUMENTS
Regulation (EU) 
No 
1238/2010
 of the European Parliament and of the Council of 
15 December 2010
 amending Annex I to Council Regulation (EEC) 
No 2658/87
 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals (OJ L 348, 
31.12.2010
, 
pp. 36–73
).
Council Regulation (EC) 
No 
467/97
 of 
3 March 1997
 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical (OJ L 71, 
13.3.1997
, 
pp. 1–15
).
RELATED DOCUMENTS
Council Regulation (EEC) 
No 
2658/87
 of 
23 July 1987
 on the tariff and statistical nomenclature and on the Common Customs Tariff (OJ L 256, 
7.9.1987
, 
pp. 1–675
).
Successive amendments to Regulation (EEC) 
No 2658/87
 have been incorporated in the original text. This 
consolidated version
 is of documentary value only.
last update 
14.12.2021

--- DANISH ---

Document:
$da_document

Summary:
$da_summary